NYSE:ALBAlbemarle Stock Price, Forecast & News

Albemarle's stock was trading at $70.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ALB stock has increased by 12.6% and is now trading at $78.89. View which stocks have been most impacted by Coronavirus.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 14 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Albemarle.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Albemarle.

Albemarle will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Albemarle Co. (NYSE:ALB) released its quarterly earnings results on Wednesday, May, 6th. The specialty chemicals company reported $1.00 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.85 by $0.15. The specialty chemicals company had revenue of $738.85 million for the quarter, compared to analysts' expectations of $769.26 million. Albemarle had a net margin of 14.50% and a return on equity of 15.34%. Albemarle's revenue was down 11.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.23 EPS. View Albemarle's earnings history.

Albemarle announced a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, June 12th will be given a dividend of $0.385 per share on Wednesday, July 1st. This represents a $1.54 annualized dividend and a yield of 1.95%. The ex-dividend date is Thursday, June 11th. View Albemarle's dividend history.

Albemarle issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $775.7 million.

25 brokers have issued 12 month target prices for Albemarle's stock. Their forecasts range from $39.50 to $116.00. On average, they expect Albemarle's stock price to reach $74.54 in the next year. This suggests that the stock has a possible downside of 5.5%. View analysts' price targets for Albemarle.

News headlines about ALB stock have been trending very negative on Monday, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Albemarle earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Albemarle.

Albemarle saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 13,970,000 shares, a drop of 9.0% from the May 31st total of 15,360,000 shares. Based on an average trading volume of 1,730,000 shares, the days-to-cover ratio is presently 8.1 days. Approximately 13.2% of the shares of the stock are sold short. View Albemarle's Current Options Chain.

Some companies that are related to Albemarle include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), NewMarket (NEU), Ashland Global (ASH), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Balchem (BCPC), PolyOne (POL), Sensient Technologies (SXT), HB Fuller (FUL), Stepan (SCL) and Innospec (IOSP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Robecosam AG (0.14%), Envestnet Asset Management Inc. (0.10%), Moody National Bank Trust Division (0.04%), State of Alaska Department of Revenue (0.04%), Legacy Capital Partners Inc. (0.02%) and HNP Capital LLC (0.01%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, State of Alaska Department of Revenue, Municipal Employees Retirement System of Michigan, Moody National Bank Trust Division, and Legacy Capital Partners Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier. View insider buying and selling activity for Albemarle.

ALB stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., HNP Capital LLC, Fulton Breakefield Broenniman LLC, Exane Derivatives, Bangor Savings Bank, Contravisory Investment Management Inc., and Ellevest Inc.. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris. View insider buying and selling activity for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $78.89.

Albemarle has a market capitalization of $8.39 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

The official website for Albemarle is www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]